Imperato A, Puglisi-Allegra S, Zocchi A, Scrocco M G, Casolini P, Angelucci L
Istituto di Farmacologia Medica 2nda Cattedra, Università La Sapienza, Roma, Italy.
Eur J Pharmacol. 1990 Jan 10;175(2):211-4. doi: 10.1016/0014-2999(90)90233-v.
Systemic administration of the 5-HT3 receptor antagonist ICS 205-930, but not of the benzodiazepine diazepam, was able to prevent the stimulation of dopamine release in the nucleus accumbens and prefrontal cortex induced by restraint stress. These findings suggest that stress is not simply co-extensive with anxiety and that 5-HT3 receptors could regulate the dopaminergic response to stress.
5-羟色胺3(5-HT3)受体拮抗剂ICS 205-930经全身给药可防止束缚应激诱导的伏隔核和前额叶皮质中多巴胺释放的增加,而苯二氮䓬类地西泮则无此作用。这些发现表明,应激并非简单地与焦虑共存,且5-HT3受体可能调节对应激的多巴胺能反应。